|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02096 SIMCERE PHARMA
Nominal 
9.870 +0.220 (+2.280%) | 2025/12 - Final RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 2,013,530 | 1,391,132 | 151,048 | 1,354,099 | (201,970) |
| Net Cash from / (used in) Investing Activities | (1,330,672) | (1,072,703) | 1,087,807 | 68,306 | (435,503) |
| Net Cash from / (used in) Financing Activities | 894,387 | (376,563) | (894,834) | (753,681) | (1,624,531) |
| Increase / (Decrease) in Cash & Cash Equivalents | 1,577,245 | (58,134) | 344,021 | 668,724 | (2,262,004) |
| Cash & Cash Equivalents at beginning of period | 1,952,586 | 2,008,434 | 1,658,312 | 974,464 | 3,270,241 |
| Effect of Foreign Exchange Rate Changes | (17,743) | 2,286 | 4,829 | 15,124 | (35,098) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 3,512,088 | 1,952,586 | 2,007,162 | 1,658,312 | 973,139 |
| Remarks: | Real time quote last updated: 05/06/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,344,008 |
| %Change | 86.150% |
| EPS / (LPS) | RMB 0.540 |
| NBV Per Share (¥) | RMB 3.624 |